
Frovatriptan (trade name Frova) is a triptan drug developed by Vernalis for the treatment of migraine headaches and for short term prevention of menstrual migraine. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe.
- ProName: Frovatriptan Succinate
- CasNo: 158930-09-7
- Appearance: White-Off White Powder
- Application: Bulk Drug for Pharmaceutical Formulati…
- DeliveryTime: Prompt
- PackAge: As per client requirement
- Port: Shanghai/Qingdao /Hongkong
- Purity: >98%
- Storage: Store in Cool, dry place with proper v…
- Transportation: As per Client Requirement- Air/Sea/Cou…
- LimitNum: 0
- Related Substances: As per Specified limits
- Residue on Ignition: As per Analysis Report
- Heavy Metal: Within Specified limits
No comments:
Post a Comment